Viewing data from:

NEMBUTAL SODIUM

ANDA

PENTOBARBITAL SODIUM | A084095 | EPIC PHARMA LLC

1 strength0 unique patents0 unique exclusivities

Medicare Part B Spending

CMS physician-administered drug spending for Nembutal Sodium (2023)

Total Spending

$276K

Total Claims

1,889

Beneficiaries

1,503

ASP Price

$40.13

YoY Change:-2.6%

5yr CAGR:+4.2%

HCPCS: J2560 — Injection, phenobarbital sodium, up to 120 mg

Source: CMS Medicare Part B Spending by Drug (2023). Shows physician-administered drug costs.

API Supply Chain0 active DMFs1 inactive

0 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

CHEMISCHE FABRIK BERG GMBHInactivePENTOBARBITAL SODIUM USP

DMF 192622006

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 30MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.